Emergent BioSolutions (EBS) is up 9.0%, or 42c to $5.08.
Easter Sale - 70% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent BioSolutions announces $50M stock repurchase program
- Emergent Biosolutions’ Strategic Investments and Divestitures Justify Buy Rating
- Hikma Pharmaceuticals announces Health Canada approval of KLOXXADO nasal spray
- Emergent BioSolutions announces $27M in incremental sales
- Emergent BioSolutions reinforces commitment to expanding access to NARCAN